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3Abstract
Eukaryotic gene expression involves several steps, including transcription, post-
transcriptional processing of pre-mRNA transcripts and export of the correctly processed
mRNAs from the nucleus to the cytoplasm, where translation takes place. Evidence has
accumulated suggesting that these steps are both functionally and physically coupled by
protein-protein interactions, involving proteins that bind the mRNA, packing it into
ribonucleoprotein particles (mRNPs).
In humans, the protein TAP/NXF1 interacts with mRNA export cargoes and mediates
their nuclear export by shuttling through nuclear pore complexes (NPCs). TAP is a
multidomain modular protein composed of an N-terminal mRNP-binding region and a C-
terminal NPC-binding region. TAP is believed to contact the cellular mRNA indirectly
via protein adaptors such as REF/Aly. It can also mediate the nuclear export of
exogenous and partially processed viral mRNAs containing a cis-acting Constitutive
Transport Element (CTE), which is the case for some types of simian retroviruses. The
CTE RNA binds directly to the N-terminal region of TAP and accesses the cellular
mRNA export pathway, skipping several upstream events of the mRNA maturation
process (e.g. splicing).
The purpose of this work is to characterise the surface and mode of interaction of TAP N-
terminal with the CTE RNA and some of its putative cellular adaptors, in particular the
mammalian protein REF/Aly. Given this information, we hope to advance in
understanding how TAP couples late stages of pre-mRNA processing and mRNA nuclear
export. We have used for this purpose, X-ray crystallography and multidimensional NMR
spectroscopy, in combination with small angle X-ray scattering experiments.
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